Analyst Estimates: Here's What Brokers Think Of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) After Its Third-Quarter Report [Yahoo! Finance]
SpringWorks Therapeutics, Inc. - common stock (SWTX)
Last springworks therapeutics, inc. - common stock earnings: 3/12 04:30 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
It wasn't the greatest result, with ongoing losses and revenues of US$49m falling short of analyst predictions. The losses were a relative bright spot though, with a per-share statutory loss of US$0.72 being moderately smaller than the analysts forecast. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year. Check out our latest analysis for SpringWorks Therapeutics After the latest results, the six analysts covering SpringWorks Therapeutics are now predicting revenues of US$373.7m in 2025. If met, this would reflect a major 176% improvement in revenue compared to the last 12 months. The loss per share is expected to greatly reduce in the near future, narrowing 53% to US$1.76. Yet prior to the latest earnings, the an
Show less
Read more
Impact Snapshot
Event Time:
SWTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SWTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SWTX alerts
High impacting SpringWorks Therapeutics, Inc. - common stock news events
Weekly update
A roundup of the hottest topics
SWTX
News
- Wedbush ups SpringWorks target to $81, expects Merck KGaA ‘official' offer soon [Yahoo! Finance]Yahoo! Finance
- Germany's Merck In Talks To Buy Cancer Drug Maker SpringWorks Therapeutics [Yahoo! Finance]Yahoo! Finance
- InnovationRx: Federal Judges Halt Trump’s Cuts To NIH Research Payments [Forbes]Forbes
- SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) had its price target raised by analysts at Evercore ISI from $60.00 to $65.00. They now have an "outperform" rating on the stock.MarketBeat
- SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $74.00 price target on the stock.MarketBeat
SWTX
Earnings
- 11/12/24 - Beat
SWTX
Sec Filings
- 2/14/25 - Form 4
- 2/14/25 - Form 144
- 2/14/25 - Form SCHEDULE
- SWTX's page on the SEC website